Therapeutic Outcomes and Biomarker Potential of CDKL3 of Neoadjuvant Chemotherapy in Patients With Stage IIIC Versus Stage IV Epithelial Ovarian Cancer From the Tempus Database, we retrospectively ...
Study reveals how our immune system transforms across a lifetime—unlocking the potential for predicting disease risk and optimizing health before symptoms appear. Resource: Integrating single-cell RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback